To see the other types of publications on this topic, follow the link: Escherichia coli infections in animals.
Journal articles on the topic 'Escherichia coli infections in animals'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Escherichia coli infections in animals.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
1
Cooke, E. Mary. "Escherichia coli – an overview." Journal of Hygiene 95, no. 3 (December 1985): 523–30. http://dx.doi.org/10.1017/s022217240006065x.
Full textAbstract:
The isolation and description of Bacillus coli commune by Escherich a hundred years ago marked the start of a series of scientific investigations which have led to some of the most important discoveries in microbial pathogenicity and genetics that have been made since that time. It is not difficult to find the reasons why so much effort has been concentrated on this organism. Escherichia coli is present in the gut of all warm-blooded animals generally forming the predominant aerobic flora; it is of medical and veterinary importance being responsible for a variety of infections in the human and animal populations and it has provided a useful tool for geneticists.
2
Allerberger, F., M. Wagner, P. Schweiger, H. P. Rammer, A. Resch, M. P. Dierich, A. W. Friedrich, and H. Karch. "Escherichia coli O157 infections and unpasteurised milk." Eurosurveillance 6, no. 10 (October 1, 2001): 147–51. http://dx.doi.org/10.2807/esm.06.10.00379-en.
Full textAbstract:
We report on two children with Escherichia coli O157 infection, one of whom developed haemolytic uraemic syndrome (HUS). Both had drunk raw cows’ or goats’ milk in the week before their illness. Molecular subtyping identified a sorbitol fermenting Escherichia coli O157:H isolate from a dairy cow. This isolate differed from Shiga toxin producing O157:H strains isolated from the 6 year old boy with HUS. This result underlines the need to search for other causes of infection, despite documented consumption of unpasteurised milk. In the second patient, human sorbitol non-fermenting O157:H isolates and animal isolates from goats were indistinguishable. The isolation of indistinguishable sorbitol non-fermenting Escherichia coli O157:H from contact animals supports the association between HUS and consumption of raw goats’ milk, and re-emphasises the importance of pasteurising milk.
3
LEIMI, ANNA, ANTTI MIKKELÄ, and PIRKKO TUOMINEN. "Evaluating Escherichia coli O157 Control in Finnish Primary Production." Journal of Food Protection 77, no. 3 (March 1, 2014): 371–79. http://dx.doi.org/10.4315/0362-028x.jfp-13-231.
Full textAbstract:
Enterohemorrhagic Escherichia coli (EHEC) has become a threat in the modern cattle sector because of its adverse impact on human health. Systems have been developed to reduce the risk of EHEC infection associated with the beef production chain. In Finland, the risk management of EHEC is mainly targeted at primary production, which is controlled by a national program. The prevalence of E. coli O157 in slaughter animals and herds appears to have remained relatively low over the years (0.2 to1.2%and 0.3 to 1.5%, respectively). The effectiveness of the Finnish EHEC control program (FECP) was analyzed with a Bayesian statistical model based on the results from 2006 through 2010. According to the model, the estimated true prevalence of EHEC in slaughter animals was at its highest in 2007 (95%credible interval [CI], 0.94 to 1.85%of animals), and the estimated true prevalence in herds was its highest in 2007 (95% CI, 1.28 to 2.55% of herds). However, the estimated probability of the FECP detecting an EHEC-positive slaughter animal or herd was 0.52 to 0.58%and 4.74 to 6.49%, respectively. The inability to detect EHEC-positive animals was partly due to animal-based random sampling, which ignores herd-level testing and therefore emphasizes the testing of slaughter animals from herds that send more animals to slaughter. Some slaughterhouses collected samples incorrectly as a consequence of an incorrectly implemented FECP. Farmers may also have questionable reasons for choosing to send animals to be slaughtered in small abattoirs, in which testing is less likely, to avoid suspicion of EHEC or other zoonotic infections.
4
LIU, W. C., C. JENKINS, D. J. SHAW, L. MATTHEWS, M. C. PEARCE, J. C. LOW, G. J. GUNN, H. R. SMITH, G. FRANKEL, and M. E. J. WOOLHOUSE. "Modelling the epidemiology of Verocytotoxin-producing Escherichia coli serogroups in young calves." Epidemiology and Infection 133, no. 3 (February 4, 2005): 449–58. http://dx.doi.org/10.1017/s0950268804003644.
Full textAbstract:
We investigate the epidemiology of 12 Verocytotoxin-producing Escherichia coli (VTEC) serogroups observed in a calf cohort on a Scottish beef farm. Fitting mathematical models to the observed time-course of infections reveals that there is significant calf-to-calf transmission of VTEC. Our models suggest that 40% of all detected infections are from calf-to-calf transmission and 60% from other sources. Variation in the rates at which infected animals recover from infection by different VTEC serogroups appears to be important. Two thirds of the observed VTEC serogroups are lost from infected calves within 1 day of infection, while the rest persist for more than 3 days. Our study has demonstrated that VTEC are transmissible between calves and are typically lost from infected animals in less than 1 week. We suggest that future field studies may wish to adopt a tighter sampling frame in order to detect all circulating VTEC serogroups in similar animal populations.
5
Martinez-Medina, Margarita. "Special Issue: Pathogenic Escherichia coli: Infections and Therapies." Antibiotics 10, no. 2 (January 25, 2021): 112. http://dx.doi.org/10.3390/antibiotics10020112.
Full textAbstract:
Escherichia coli is a facultative anaerobic Gram-negative bacterium from the Enterobacteriaceae family that colonizes the gastrointestinal tract of warm-blooded animals shortly after birth, and it is a lifelong colonizer of adults [...]
6
Terekhov, Vladimir I., Aleksandr S. Tishchenko, and Anastasiya V. Stepanenko. "Exotoxins of pathogenic Escherichia coli." Veterinaria Kubani, no. 5 (October 30, 2020): 3–7. http://dx.doi.org/10.33861/2071-8020-2020-5-3-7.
Full textAbstract:
Escherichia coli is a representative of the natural normal microflora of humans and animals. At the same time, some variants may acquire pathogenic properties that contribute to the occurrence of intestinal and extraintestinal infections. In the pathogenesis of these diseases, the main role is played by exotoxins. Currently, along with the well-known and well-studied toxins of Escherichia coli, there is information about new toxoid structures detected in this pathogen, which play an important role in pathologies in humans and animals. Authors summarized current data on the toxigenic properties of Escherichia coli bacteria and established the role of exotoxins of pathogenic Escherichia coli in the mechanism of disease development. Scientific publications of mainly foreign researchers were used as a material for the review. It was found that cyclodomodulating exotoxins that affect the eukaryotic cell cycle were currently identified in Escherichia coli in addition to thermolabile, thermostable, shigalike, necrotizing toxins and hemolysin. Also Escherichia coli has a number of pore-forming toxins that destroy the epithelial barrier and overcome the protection of the host's immune cells due to the formation of pores in their membranes, and so-called repeated toxins, the prototype of which is а-hemolysin. Thus, it can be seen from the review that Escherichia coli, having a wide range of toxoid structures, can cause pathological changes in the human and animal body. The nature of these changes directly depends on the type of E. coli and the type of exotoxin produced by them. Most toxigenic strains of Escherichia coli have the ability to modulate the expression of proinflammatory cytokines, chemokines and other immune cells, which can be further used in the design of effective vaccines and biological products for the treatment and prevention of enterobacterial infections.
7
Moxley, Rodney A., and David R. Smith. "Attaching-effacing Escherichia coli Infections in Cattle." Veterinary Clinics of North America: Food Animal Practice 26, no. 1 (March 2010): 29–56. http://dx.doi.org/10.1016/j.cvfa.2009.10.011.
Full text
8
García, Alexis, and James G. Fox. "A One Health Perspective for Defining and Deciphering Escherichia coli Pathogenic Potential in Multiple Hosts." Comparative Medicine 71, no. 1 (February 1, 2021): 3–45. http://dx.doi.org/10.30802/aalas-cm-20-000054.
Full textAbstract:
E. coli is one of the most common species of bacteria colonizing humans and animals. The singularity of E. coli 's genus and species underestimates its multifaceted nature, which is represented by different strains, each with different combinations of distinct virulence factors. In fact, several E. coli pathotypes, or hybrid strains, may be associated with both subclinical infection and a range of clinical conditions, including enteric, urinary, and systemic infections. E. coli may also express DNA-damaging toxins that could impact cancer development. This review summarizes the different E. coli pathotypes in the context of their history, hosts, clinical signs, epidemiology, and control. The pathotypic characterization of E. coli in the context of disease in different animals, including humans, provides comparative and One Health perspectives that will guide future clinical and research investigations of E. coli infections.
9
Półtorak, Katarzyna, Kinga Wieczorek, and Jacek Osek. "Pathogenic Escherichia coli – virulence mechanisms." Medycyna Weterynaryjna 72, no. 6 (2016): 352–57. http://dx.doi.org/10.21521/mw.5522.
Full textAbstract:
E. coli are the predominant microorganisms in the human gastrointestinal tract. In most cases, they exist as harmless comensals, and some of them are beneficial to their host in balancing gut flora and absorption of nutrients. However, there are pathogenic strains that cause a broad range of diseases in humans and animals, from diarrhea to bloodstream infections. Among bacterial strains causing these symptoms, seven pathotypes are now recognized: enteropathogenic E. coli (EPEC), shiga toxin-producing E. coli (STEC), enterotoxigenic E. coli (ETEC), enteroinvasive E. coli (EIEC), enteroaggregative E. coli (EAEC), diffusely adherent E. coli (DAEC), and adherent-invasive E. coli (AIEC). Several different strains cause diverse diseases by means of virulence factors that facilitate their interactions with the host, including colonization of the intestinal epithelial surfaces, crossing of the mucosal barriers, invasion of the bloodstream and internal organs or producing toxins that affect various cellular processes. Pathogenic E. coli are commonly studied in humans, animals, food and the environment, in developed and developing countries. The presented paper reviews recent information concerning the pathogenic mechanisms of E. coli, the role of animals and food in the transmission chain and a short overview of epidemiological data.
10
Moon, Harley W. "Vaccines for preventing enterotoxigenic Escherichia coli infections in farm animals." Vaccine 10, no. 4 (January 1992): 269–70. http://dx.doi.org/10.1016/0264-410x(92)90194-o.
Full text
11
Moon, Harley W., and Thomas O. Bunn. "Vaccines for preventing enterotoxigenic Escherichia coli infections in farm animals." Vaccine 11, no. 2 (January 1993): 213–20. http://dx.doi.org/10.1016/0264-410x(93)90020-x.
Full text
12
Soares, Mirella Tomaz, Gerson Nakazato, Renata K. T. Kobayaski, and Marcelo de Souza Zanutto. "Escherichia coli in dogs and cats and its zoonotic potential – a review." Clínica Veterinária XXVII, no. 156 (January 2, 2022): 32–43. http://dx.doi.org/10.46958/rcv.2022.xxvii.n.156.p.32-43.
Full textAbstract:
While diseases in humans seem to be an isolated concern, many are caused by zoonotic agents. The increasingly close contact between pets and their guardians must be considered, and investigations related to pathogens that are frequently found in humans and other animals must be carried out. Escherichia coli, in addition to being a commensal bacterium found in the intestinal tract of many animals, is one of the most frequent causes of several bacterial infections. Recent studies indicate that contact between humans and animals could contribute to the transmission between species of E. coli strains that produce extended-spectrum β-lactamases (ESBL) and AmpC-type lactamases, which are antimicrobial-resistant (multi-resistant). However, more studies are needed for these assumption to be confirmed. This review addresses the zoonotic potential of E. coli based on research related to the finding of pathogenic strains in animals and humans.
13
Adesiyun, A. A., J. S. Kaminjolo, M. Ngeleka, A. Mutani, G. Borde, W. Harewood, and W. Harper. "A longitudinal study on enteropathogenic infections of livestock in Trinidad." Revista da Sociedade Brasileira de Medicina Tropical 34, no. 1 (February 2001): 29–35. http://dx.doi.org/10.1590/s0037-86822001000100005.
Full textAbstract:
A longitudinal study was conducted on selected livestock farms to determine the prevalence of enteropathogens in diarrhoeic and non-diarrhoeic animals. The enteropathogens assayed from faecal samples and rectal swabs were bacteria (Escherichia coli, Campylobacter spp. Salmonella spp. and Yersinia enterocolitica), parasites (coccidia, gastrointestinal nematodes and Cryptosporidium spp.) and viruses (group A rotavirus and parvovirus). The prevalence of the enteropathogens in various animal species was related to age and month of the year. Generally, younger animals presented a higher prevalence of infection by enteropathogens than older animals while most infections occurred between the months of January and April.
14
Samokovlija, Ana, and Bosiljka Djuricic. "Escherichia coli: Old problem, new pathology." Veterinarski glasnik 63, no. 1-2 (2009): 113–23. http://dx.doi.org/10.2298/vetgl0902113s.
Full textAbstract:
Even though the presence of Escherichia coli in the organism of humans and animals as a commensal has been known for a long time, attention has been paid to it only recently as the cause of diseases in humans and animals. The disease that is caused by this bacteria is linked to new variants-strains (eg. Verotoxic 0157:H7) which have, due to the toxic effects, a pathogensis and clinical picture that differs from those which have so far been linked to the conventional E.coli. Namely, it has been proved that there is a connection between the presence of certain strains of this bacteria in animals in which there is no occurrence of clinical symptoms, and diseased humans who had come into contact with these animals. Since infection with E.coli is transferred also through food items of animal origin, and in keeping with the valid regulations on hygiene safety of food items, increasing importance is placed on the isolation and identification of this bacteria on the slaughter line. It has also been accepted that it is necessary to apply screening among animal populations, as the basic step in the control and eradication of pathogens. There are few data on the distribution of verotoxic E.coli and the number of reported cases of infection in humans in Serbia, and they do not provide the real picture of the epizootiological-epidemiological situation. Verotoxic E.coli occurred over the past two decades as an important cause of morbidity and mortality in humans and animals. Due to the large number of cases that are linked, directly or indirectly, with food items of animal origin, there have been major economic losses as well.
15
Gibson, Justine S., Rowland N. Cobbold, and Darren J. Trott. "Characterization of multidrug-resistant Escherichia coli isolated from extraintestinal clinical infections in animals." Journal of Medical Microbiology 59, no. 5 (May 1, 2010): 592–98. http://dx.doi.org/10.1099/jmm.0.018002-0.
Full textAbstract:
Multidrug-resistant (MDR) Escherichia coli causes extraintestinal infections in both humans and animals. This study aimed to determine whether MDR E. coli isolates cultured from extraintestinal infections in several animal species were clonal and crossed host-species boundaries, as suggested by initial characterization of a subset of canine and human isolates, or whether they represented a diverse group of host-specific strains. Isolates were obtained either from The University of Queensland Veterinary Diagnostic Laboratory or from an independent diagnostic laboratory between October 1999 and December 2007. Ninety-six MDR E. coli isolates cultured from extraintestinal clinical infections in 55 animals comprising dogs (n=45), cats (n=5), horses (n=4) and a koala (n=1) were analysed by phylogenetic grouping, antimicrobial susceptibility testing and PFGE. The isolates were cultured from the urinary tract (n=61), reproductive tract (n=11), wounds (n=11), surgical site infections (n=4) and other sites (n=9). Isolates from the same E. coli phylogenetic group with 100 % PFGE similarity and the same antimicrobial susceptibility pattern were considered to be repeat clones and excluded from further analysis. Three of the four E. coli phylogenetic groups (A, n=19; B1, n=8; and D, n=49) were represented. Analysis of PFGE similarity identified clusters of related phylogenetic group A isolates [clonal group (CG) 1] and group D isolates (CG2 and CG3), with the remainder of the isolates demonstrating diversity. The majority of CG2 isolates contained a plasmid-borne AmpC β-lactamase, imparting resistance to cefoxitin and third-generation cephalosporins, and were obtained between 2000 and 2003. CG3 isolates were sensitive to these antimicrobial agents and appeared to replace CG2 isolates as the dominant clones from 2003 to 2007. Apart from several canine and feline isolates that demonstrated clonality, PFGE profiles tended to be divergent across species. Whilst MDR E. coli isolates from extraintestinal infections in different animal species are diverse, some dominant CGs may persist over several years.
16
Brüssow, Harald. "Phage therapy: the Escherichia coli experience." Microbiology 151, no. 7 (July 1, 2005): 2133–40. http://dx.doi.org/10.1099/mic.0.27849-0.
Full textAbstract:
Phages have been proposed as natural antimicrobial agents to fight bacterial infections in humans, in animals or in crops of agricultural importance. Phages have also been discussed as hygiene measures in food production facilities and hospitals. These proposals have a long history, but are currently going through a kind of renaissance as documented by a spate of recent reviews. This review discusses the potential of phage therapy with a specific example, namely Escherichia coli.
17
Cornick, Nancy A., and Hung VuKhac. "Indirect Transmission of Escherichia coli O157:H7 Occurs Readily among Swine but Not among Sheep." Applied and Environmental Microbiology 74, no. 8 (February 29, 2008): 2488–91. http://dx.doi.org/10.1128/aem.02897-07.
Full textAbstract:
ABSTRACT Transmission of Escherichia coli O157:H7 among reservoir animals is generally thought to occur either by direct contact between a naïve animal and an infected animal or by consumption of food or water containing the organism. Although ruminants are considered the major reservoir, there are two reports of human infections caused by E. coli O157:H7 linked to the consumption of pork products or to the contamination of fresh produce by swine manure. The objective of this study was to determine whether E. coli O157:H7 could be transmitted to naïve animals, both sheep and swine, that did not have any direct contact with an infected donor animal. We recovered E. coli O157:H7 from 10/10 pigs with nose-to-nose contact with the infected donor or animals adjacent to the donor and from 5/6 naïve pigs that were penned in the same room as the donor pig but 10 to 20 ft away. In contrast, when the experiment was repeated with sheep, E. coli O157:H7 was recovered from 4/6 animals that had nose-to-nose contact with the infected donor or adjacent animals and from 0/6 naïve animals penned 10 to 20 ft away from the donor. These results suggest that E. coli O157:H7 is readily transmitted among swine and that transmission can occur by the creation of contaminated aerosols.
18
Hovde, Carolyn J., Paula R. Austin, Karen A. Cloud, Christopher J. Williams, and Carl W. Hunt. "Effect of Cattle Diet on Escherichia coli O157:H7 Acid Resistance." Applied and Environmental Microbiology 65, no. 7 (July 1, 1999): 3233–35. http://dx.doi.org/10.1128/aem.65.7.3233-3235.1999.
Full textAbstract:
ABSTRACT The duration of shedding of Escherichia coli O157 isolates by hay-fed and grain-fed steers experimentally inoculated withE. coli O157:H7 was compared, as well as the acid resistance of the bacteria. The hay-fed animals shed E. coli O157 longer than the grain-fed animals, and irrespective of diet, these bacteria were equally acid resistant. Feeding cattle hay may increase human infections with E. coli O157:H7.
19
Münnich, A., and A. Lübke-Becker. "Escherichia coli infections in newborn puppies—clinical and epidemiological investigations." Theriogenology 62, no. 3-4 (August 2004): 562–75. http://dx.doi.org/10.1016/j.theriogenology.2003.11.012.
Full text
20
Ramos, Sónia, Vanessa Silva, Maria de Lurdes Enes Dapkevicius, Manuela Caniça, María Teresa Tejedor-Junco, Gilberto Igrejas, and Patrícia Poeta. "Escherichia coli as Commensal and Pathogenic Bacteria among Food-Producing Animals: Health Implications of Extended Spectrum β-Lactamase (ESBL) Production." Animals 10, no. 12 (November 29, 2020): 2239. http://dx.doi.org/10.3390/ani10122239.
Full textAbstract:
Escherichia coli are facultative, anaerobic Gram-negative rods with many facets. Within resistant bacterial populations, they play an important ecological role and can be used as a bioindicator of antimicrobial resistance. All animal species used for food production, as well as humans, carry E. coli in their intestinal tracts; plus, the genetic flexibility and adaptability of this bacteria to constantly changing environments allows it to acquire a great number of antimicrobial resistance mechanisms. Thus, the prevalence of antimicrobial resistance in these commensal bacteria (or others, such as enterococci) can be a good indicator for the selective pressure caused by the use of antimicrobial agents, providing an early warning of the emergence of antimicrobial resistance in pathogens. As many as 90% of E. coli strains are commensals inhabiting the intestinal tracts of humans and warm-blooded animals. As a commensal, it lives in a mutually beneficial association with its hosts and rarely causes diseases. However, E. coli also remains as one of the most frequent causes of several common bacterial infections in humans and animals. In humans, it is the prominent cause of enteritis, community- and hospital-acquired urinary tract infection (UTI), septicemia, postsurgical peritonitis, and other clinical infections, such as neonatal meningitis, while, in farm animals, it is more prominently associated with diarrhea. On a global scale, E. coli can be considered the most important human pathogen, causing severe infection along with other major bacterial foodborne agents, such as Salmonella spp. and Campylobacter. Thus, the importance of resistance in E. coli, typically considered a benign commensal, should not be underestimated.
21
Janke, Bruce H., David H. Francis, James E. Collins, Melissa C. Libal, David H. Zeman, and Darrell D. Johnson. "Attaching and Effacing Escherichia coli Infections in Calves, Pigs, Lambs, and Dogs." Journal of Veterinary Diagnostic Investigation 1, no. 1 (January 1989): 6–11. http://dx.doi.org/10.1177/104063878900100104.
Full textAbstract:
Attaching and effacing Escherichia coli (AEEC) adhere to mucosal epithelium in both small and large intestine and induce a distinctive lesion characterized by an irregular scalloped appearance of the epithelial layer. Infection with attaching and effacing E. coli was detected in 14 calves, 7 pigs, 2 lambs, and 3 dogs. Affected animals were from farms and kennels in South Dakota, Minnesota, Iowa, Nebraska, and Wisconsin. Ages of affected animals were calves, 2 days to 4 months; pigs, 1–6 weeks; lambs, 1 week; and dogs, 7–8 weeks. Clinical signs included diarrhea in all animals, but other nonenteric disease problems were present in some animals. Concurrent infection with other enteropathogens was detected in 9 calves and 5 pigs. Infection with AEEC appeared to be the sole cause of illness and death in some animals. There was evidence of intestinal hemorrhage in 5 of the calves and in all 3 dogs. Attaching and effacing lesions varied from small scattered foci to widespread involvement of large areas of intestinal mucosa. Verotoxin was produced by E. coli strains isolated from 9 calves, but not by strains from pigs, lambs, or dogs.
22
Torres, Alfredo, Maria Amaral, Leticia Bentancor, Lucia Galli, Jorge Goldstein, Alejandra Krüger, and Maricarmen Rojas-Lopez. "Recent Advances in Shiga Toxin-Producing Escherichia coli Research in Latin America." Microorganisms 6, no. 4 (September 28, 2018): 100. http://dx.doi.org/10.3390/microorganisms6040100.
Full textAbstract:
Pathogenic Escherichia coli are known to be a common cause of diarrheal disease and a frequently occurring bacterial infection in children and adults in Latin America. Despite the effort to combat diarrheal infections, the south of the American continent remains a hot spot for infections and sequelae associated with the acquisition of one category of pathogenic E. coli, the Shiga toxin-producing E. coli (STEC). This review will focus on an overview of the prevalence of different STEC serotypes in human, animals and food products, focusing on recent reports from Latin America outlining the recent research progress achieved in this region to combat disease and endemicity in affected countries and to improve understanding on emerging serotypes and their virulence factors. Furthermore, this review will highlight the progress done in vaccine development and treatment and will also discuss the effort of the Latin American investigators to respond to the thread of STEC infections by establishing a multidisciplinary network of experts that are addressing STEC-associated animal, human and environmental health issues, while trying to reduce human disease. Regardless of the significant scientific contributions to understand and combat STEC infections worldwide, many significant challenges still exist and this review has focus in the Latin American efforts as an example of what can be accomplished when multiple groups have a common goal.
23
Cornick, N. A., and A. F. Helgerson. "Transmission and Infectious Dose of Escherichia coli O157:H7 in Swine." Applied and Environmental Microbiology 70, no. 9 (September 2004): 5331–35. http://dx.doi.org/10.1128/aem.70.9.5331-5335.2004.
Full textAbstract:
ABSTRACT Escherichia coli O157:H7 is only occasionally isolated from healthy swine, but some experimentally infected animals will shed the organism in their feces for at least 2 months. Potential explanations for the paucity of naturally occurring infections in swine, as compared to cattle, include a lack of animal-to-animal transmission so that the organism cannot be maintained within a herd, a high infectious dose, or herd management practices that prevent the maintenance of the organism in the gastrointestinal tract. We hypothesized that donor pigs infected with E. coli O157:H7 would transmit the organism to naïve pigs. We also determined the infectious dose and whether housing pigs individually on grated floors would decrease the magnitude or duration of fecal shedding. Infected donor pigs shedding <104 CFU of E. coli O157:H7 per g transmitted the organism to 6 of 12 naïve pigs exposed to them. The infectious dose of E. coli O157:H7 for 3-month-old pigs was approximately 6 × 103 CFU. There was no difference in the magnitude and duration of fecal shedding by pigs housed individually on grates compared to those housed two per pen on cement floors. These results suggest that swine do not have an innate resistance to colonization by E. coli O157:H7 and that they could serve as a reservoir host under suitable conditions.
24
Guerra, Simony Trevizan, Carolina Lechinski de Paula, Carmen Alicia Daza Bolaños, Rodrigo Tavanelli Hernandes, and Márcio Garcia Ribeiro. "Virulence factors of Escherichia coli: an overview of animal and human infections with emphasis in bovine mastitis." Semina: Ciências Agrárias 40, no. 5 (July 4, 2019): 2087. http://dx.doi.org/10.5433/1679-0359.2019v40n5p2087.
Full textAbstract:
Escherichia coli is a normal inhabitant of the enteric microflora of human and animal. Intestinal and extra-intestinal infections caused by E. coli in mammals are characterized by the presence of diversity of virulence factors. In addition it can be isolated from environment surrounding human and animal farms. E. coli is the main environmental pathogen causing clinical mastitis in dairy cattle. It causes a wide range of disease severity, from changes seen exclusively in milk to severe systemic signs. The severity of clinical mastitis has been conventionally classified into three levels: mild (grade 1), moderate (score 2), and severe (score 3). Recently, reports of cases of bovine mastitis caused by environmental agents have been on the rise, in particular in countries that have succeeded in controlling contagious microorganisms. Unlike enteric and certain extra-enteric conditions in domestic animals and humans, the impact of virulence factors on the occurrence of bovine mastitis due to E. coli, as well as the clinical severity of the cases, is not fully understood. In this regard, the present study reviewed the most relevant virulence factors of E. coli in human and animals, with emphasis in bovine mastitis.
25
Jakobsen, Lotte, Anette M. Hammerum, and Niels Frimodt-Møller. "Detection of Clonal Group A Escherichia coli Isolates from Broiler Chickens, Broiler Chicken Meat, Community-Dwelling Humans, and Urinary Tract Infection (UTI) Patients and Their Virulence in a Mouse UTI Model." Applied and Environmental Microbiology 76, no. 24 (October 29, 2010): 8281–84. http://dx.doi.org/10.1128/aem.01874-10.
Full textAbstract:
ABSTRACT Escherichia coli clonal group A isolates cause infections in people. We investigated 158 phylogroup D E. coli isolates from animals, meat, and humans. Twenty-five of these isolates were of clonal group A, and 15 isolates were shown to cause infection in a mouse urinary tract infection (UTI) model. We conclude that clonal group A isolates are found in both broiler chickens and broiler chicken meat and may cause UTI in humans.
26
Sheng, Haiqing, Margaret A. Davis, Hannah J. Knecht, and Carolyn J. Hovde. "Rectal Administration of Escherichia coli O157:H7: Novel Model for Colonization of Ruminants." Applied and Environmental Microbiology 70, no. 8 (August 2004): 4588–95. http://dx.doi.org/10.1128/aem.70.8.4588-4595.2004.
Full textAbstract:
ABSTRACT Escherichia coli O157:H7 causes hemorrhagic colitis and life-threatening complications. Because healthy cattle are reservoirs for the bacterium, ruminant infection models have applications in analyzing the relationship between cattle and this human pathogen and in testing interventions to reduce or prevent bovine colonization with this bacterium. Current approaches often do not reliably mimic natural, long-term bovine colonization with E. coli O157:H7 in older calves and adult animals (ages that enter our food chain). Based on the recent identification of the bovine rectoanal junction mucosa as a site of E. coli O157:H7 colonization, we developed a novel rectal swab administration colonization model. We compared this method with oral dosing and direct contact transmission (Trojan) methods. E. coli O157:H7 carriage status was determined by fecal or rectoanal mucosa swab culture. High (∼1010 CFU) and low (∼107 CFU) oral doses of E. coli O157:H7 in sheep and cattle resulted in variable infection with the bacterium. Some animals became colonized with the bacteria and remained culture positive for several weeks, and some animals did not become colonized and rapidly cleared the bacteria in a few days. Pen mates of E. coli O157:H7 culture-positive Trojan cattle had a low infection rate and variable colonization status. However, rectal swab administration of E. coli O157:H7 to cattle resulted in consistent long-term colonization in all animals. The surprising ease with which long-term infections resulted from a single application of bacteria to the rectoanal mucosa also strongly supported this location as a site of E. coli O157:H7 colonization in cattle.
27
La Ragione, R. M., N. MY Ahmed, A. Best, D. Clifford, U. Weyer, W. A. Cooley, L. Johnson, G. R. Pearson, and M. J. Woodward. "Colonization of 8-week-old conventionally reared goats by Escherichia coli O157 : H7 after oral inoculation." Journal of Medical Microbiology 54, no. 5 (May 1, 2005): 485–92. http://dx.doi.org/10.1099/jmm.0.45897-0.
Full textAbstract:
Enterohaemorrhagic Escherichia coli O157 : H7 infections of man have been associated with consumption of unpasteurized goat's milk and direct contact with kid goats on petting farms, yet little is known about colonization of goats with this organism. To assess the contribution of flagella and intimin of E. coli O157 : H7 in colonization of the goat, 8-week-old conventionally reared goats were inoculated orally in separate experiments with 1×1010 c.f.u. of a non-verotoxigenic strain of E. coli O157 : H7 (strain NCTC 12900 Nalr), an aflagellate derivative (DMB1) and an intimin-deficient derivative (DMB2). At 24 h after inoculation, the three E. coli O157 : H7 strains were shed at approximately 5×104 c.f.u. (g faeces)−1 from all animals. Significantly fewer intimin-deficient bacteria were shed only on days 2 (P = 0.003) and 4 (P = 0.014), whereas from day 7 to 29 there were no differences. Tissues from three animals inoculated with wild-type E. coli O157 : H7 strain NCTC 12900 Nalr were sampled at 24, 48 and 96 h after inoculation and the organism was cultured from the large intestine of all three animals and from the duodenum and ileum of the animal examined at 96 h. Tissues were examined histologically but attaching-effacing (AE) lesions were not observed at any intestinal site of the animals examined at 24 or 48 h. However, the animal examined at 96 h, which had uniquely shed approximately 1×107 E. coli O157 : H7 (g faeces)−1 for the preceding 3 days, showed a heavy, diffuse infection with cryptosporidia and abundant, multifocal AE lesions in the distal colon, rectum and at the recto-anal junction. These AE lesions were confirmed by immunohistochemistry to be associated with E. coli O157 : H7.
28
Green, Sabrina I., Nadim J. Ajami, Li Ma, Nina M. Poole, Roger E. Price, Joseph F. Petrosino, and Anthony W. Maresso. "Murine Model of Chemotherapy-Induced Extraintestinal Pathogenic Escherichia coli Translocation." Infection and Immunity 83, no. 8 (June 1, 2015): 3243–56. http://dx.doi.org/10.1128/iai.00684-15.
Full textAbstract:
Escherichia coliis a major cause of life-threatening infections in patients with neutropenia, particularly those receiving chemotherapy for the treatment of cancer. In most cases, these infections originate from opportunistic strains living within the patient's gastrointestinal tract which then translocate to major organ systems. There are no animal models that faithfully recapitulate these infections, and, as such, the host or bacterial factors that govern this process remain unidentified. We present here a novel model of chemotherapy-induced bacterial translocation ofE. coli. Oral gavage of BALB/c mice with a clinical isolate of extraintestinal pathogenicE. coli(ExPEC) leads to stable and long-term colonization of the murine intestine. Following the induction of neutropenia with the chemotherapeutic drug cyclophosphamide, ExPEC translocates from the intestine to the lungs, liver, spleen, and kidneys with concomitant morbidity in infected animals. Translocation can also occur in mice bearing mammary tumors, even in the absence of chemotherapy. Translocation of ExPEC is also associated with an increase of the diversity of bacterial DNA detected in the blood. This is the first report of a chemotherapy-based animal model of ExPEC translocation in cancerous mice, a system that can be readily used to identify important virulence factors for this process.
29
Gould, Jane M., Stephen D. Cole, Matthew J. Ryan, Susy Rettig, Kristin Privette, Tiina Peritz, Susan Coffin, et al. "A Collaborative Public Health and Veterinary Facility Approach to an NDM-5 Escherichia coli Outbreak." Infection Control & Hospital Epidemiology 41, S1 (October 2020): s452—s453. http://dx.doi.org/10.1017/ice.2020.1124.
Full textAbstract:
Background: Carbapenem-resistant Enterobacteriaceae (CRE) are an important cause of healthcare-associated infections (HAIs) in human hospitals. The Philadelphia Department of Public Health (PDPH) made CRE reportable in April 2018. In May 2019, the Matthew J. Ryan Veterinary Hospital (MJRVH) reported an NDM-5 Escherichia coli cluster in companion animals to the PDPH. In total, 15 infected animals (14 dogs and 1 cat) were reported between July 2018 and June 2019, with no new infections after June 2019. Limited literature is available on the prevalence of CRE in companion animals, and recommendations for dealing with CRE infections currently target human healthcare settings. Methods: A collaborative containment response included assessing interspecies transmission to veterinary staff and a comprehensive evaluation of the infection control program at MJRVH. MJRVH notified all owners of affected animals verbally and via notification letters with PDPH recommendations for CRE colonization screening of high-risk individuals. CRE screening of exposed high-risk employees was conducted by the University of Pennsylvania Occupational Health service and PDPH. Human rectal swabs were analyzed at the Antibiotic Resistance Laboratory Network (ARLN) Maryland Laboratory. PDPH were invited to conduct an onsite infection control assessment and to suggest improvements. Results: No pet owners self-identified in high-risk groups to be screened. In total, 10 high-risk staff were screened, and no colonized individuals were detected. Recommendations made by the PDPH to MJRVH included improvement of infection prevention and control policies (eg, consolidation of the infection control manual and identification of lead staff member), improvement in hand hygiene (HH) compliance (eg, increasing amount of HH supplies), improvement of environment of care (eg, decluttering and evaluation of mulched animal relief area), and improvement of respiratory care processes (eg, standardization of care policies). MJRVH made substantial improvements across recommendation areas including revision of infection control manual, creation of a full-time infection preventionist position, individual alcohol hand sanitizers for patient cages, and environmental decluttering and decontamination. PDPH and MJRVH maintained frequent communication about infection control improvements. Conclusions: No positive transmission to high-risk staff members suggest that, like in human healthcare facilities, transmission of CRE to caretakers may not be a common event. Stronger communication and collaboration is required from Departments of Public Health (DPH) to the veterinary profession regarding the reporting requirements of emerging pathogens such as CRE. Veterinary facilities should view DPH as a valuable resource for recommendations to fill in gaps that exist in infection control “best practices,” particularly for novel pathogens in veterinary settings.Funding: NoneDisclosures: Jane M. Gould reports that her spouse receives salary from Incyte.
30
Scott Weese, J. "Antimicrobial resistance in companion animals." Animal Health Research Reviews 9, no. 2 (November 5, 2008): 169–76. http://dx.doi.org/10.1017/s1466252308001485.
Full textAbstract:
AbstractAntimicrobial resistance (AMR) is an emerging problem in companion animals, because of difficult-to-treat infections, possible pressure to use antimicrobials that are important in human medicine, and potential zoonotic transmission. The extent and importance of AMR in companion animals are poorly understood, in part because of limited surveillance; however, it is clear that resistance is problematic in many pathogens and commensals, including staphylococci, enterococci, Escherichia coli and Salmonella.
31
Rankin, Shelley C., and Stephen D. Cole. "An Outbreak of New Delhi Metallo--Lactamase-5 (blaNDM-5)–Producing Escherichia coli in Companion Animals in the United States." Infection Control & Hospital Epidemiology 41, S1 (October 2020): s21. http://dx.doi.org/10.1017/ice.2020.496.
Full textAbstract:
Background: The emergence of carbapenem-resistant Enterobacteriaceae (CRE) in companion animals will be a game changer for infection prevention and control strategies in veterinary and human healthcare facilities. CRE have emerged as an important cause of human healthcare-associated infections and are a major clinical and public health problem. Although reports of CRE from animals are still very rare, they have been documented in China, Europe, and the United States. Methods: In April 2019, a passive veterinary surveillance system identified the blaNDM-5 gene in an E. coli isolated from a dog in Philadelphia in July 2018. CRE are reportable to the Philadelphia Department of Public Health (PDPH), and in May 2019, the Matthew J. Ryan Veterinary Hospital at the University of Pennsylvania (MJRVH) reported a cluster of carbapenem-resistant E. coli (CR-E. coli) isolated from 14 animals to the PDHP. This cluster of 17 isolates, that all contained a blaNDM-5 gene, was the first report of a CR-E. coli outbreak at a US veterinary facility. The first isolate, E. coli 24213-18, was sequenced on the Pacific Biosciences (PacBio) Sequel Sequencer and has been uploaded to GenBank. Whole genome sequencing was performed on all 17 isolates using the Illumina MiSeq platform. Antimicrobial resistance genes were identified from the National Center for Biotechnology Information Pathogen Detection Isolates Browser using AMRFinder. Results: PacBio sequencing confirmed E. coli ST167 and identified a circular IncFII plasmid of 139,547 bp that contained the blaNDM-5 gene, along with many additional resistance genes. In June 2019, a retrospective review of hospital records was completed and showed that, from July 2018, 17 CR- E. coli were isolated from 14 animals. Conclusions: Control of CRE infections in human healthcare settings is challenging because the organisms colonize the gastrointestinal tract and can go undetected. The same issue is to be expected with companion animals. Healthcare-associated spread of CRE E. coli in a veterinary facility emphasizes the importance of rapidly identifying and characterizing carbapenem-resistant isolates from animals. Methods to control the spread of CRE in veterinary medical settings have not yet been studied, and related investigations will be critically important to limit the transmission of these pathogens in animal populations. The risk of transmission of CRE from animals to people is currently poorly understood. CRE will be a major challenge across all health fields as these organisms become more prevalent in the community. It is likely that a ‘One Health’ approach to surveillance, infection prevention, and antimicrobial stewardship will be required to limit the spread and potential global dominance of CRE.Funding: NoneDisclosures: None
32
Antaki-Zukoski, Elizabeth, Xunde Li, Patricia Pesavento, Tran Nguyen, Bruce Hoar, and Edward Atwill. "Comparative Pathogenicity of Wildlife and Bovine Escherichia coli O157:H7 Strains in Experimentally Inoculated Neonatal Jersey Calves." Veterinary Sciences 5, no. 4 (October 15, 2018): 88. http://dx.doi.org/10.3390/vetsci5040088.
Full textAbstract:
Shiga toxin-producing Escherichia coli, like E. coli O157:H7, are important human and animal pathogens. Naturally-acquired E. coli O157:H7 infections occur in numerous species but, particularly, cattle have been identified as a significant reservoir for human cases. E. coli O157:H7 are isolated from a number of domestic and wild animals, including rodents that share a living space with cattle. These Shiga toxin-producing E. coli O157:H7 strains can be highly virulent in humans, but little is known about the sequelae of interspecies transfer. In a group of neonatal calves, we determined the differences in colonization patterns and lesions associated with infection using either a wildlife or bovine E. coli O157:H7 strain. In calves challenged with the wildlife E. coli O157:H7 strain, the large (descending) colon was solely colonized, which differed substantially from the calves inoculated with the bovine E. coli O157:H7 strain, where the spiral colon was the principal target of infection. This study also demonstrated that while both interspecies- and intraspecies-derived E. coli O157:H7 can infect young calves, the distribution and severity differs.
33
Bach, S. J., T. A. McAllister, D. M. Veira, V. P. J. Gannon, and R. A. Holley. "Transmission and control of Escherichia coli O157:H7 — A review." Canadian Journal of Animal Science 82, no. 4 (December 1, 2002): 475–90. http://dx.doi.org/10.4141/a02-021.
Full textAbstract:
Escherichia coli 157:H7 has evolved as an important foodborne pathogen since its initial description in 1982. Outbreaks of illness associated with E. coli O157:H7 have been reported throughout the northern hemisphere, most frequently in Canada, the United States, Japan, and the United Kingdom. In Canada, infections due to E. coli O157: H7 appear to be more common in the western provinces than in the east, in rural vs. urban environments, and during summer as opposed to winter months. Undercooked ground beef has been implicated as the primary vehicle in E. coli O157:H7 infection, but contaminated fruits, vegetables and water have also been linked to E. coli O157:H7 outbreaks. Epidemiological investigations demonstrate that dairy and beef cattle are primary reservoirs of this organism, carrying it asymptomatically and shedding it intermittently and seasonally in their feces. Surveys in Canada and the United States indicate widespread distribution of E. coli O157:H7 in cattle operations. The prevalence of E. coli O157:H7 in cattle has been increasing in recent reports, likely due to the development of more sensitive methods for the detection of the organism. Escherichia coli O157:H7 has been isolated from feed, water for livestock, manure, soil and flies, all of which represent potential sources of contamination for cattle and their environment. To date, effective methods for controlling E. coli O157:H7 in cattle have not been identified, although dietary manipulation, vaccination and bacteriophage therapy have been reported to have potential as intervention strategies. Effective control of E. coli O157:H7 requires reducing the frequency and intensity of fecal shedding of this pathogen by cattle, in addition to targeting environmental sources of the organism. Key words: Escherichia coli O157:H7, cattle, sources, diet, transmission
34
Wronski, Julia G., Fernando F. Argenta, Jacqueline Raiter, Luiza P. Ehlers, Rafaella D. V. Sala, Franciele M. Siqueira, Diego F. Cardoso, Luciana Sonne, and Saulo P. Pavarini. "Bilateral pyelonephritis due to Escherichia coli infection in a captive jaguar (Panthera onca)." Pesquisa Veterinária Brasileira 40, no. 7 (July 2020): 554–58. http://dx.doi.org/10.1590/1678-5150-pvb-6530.
Full textAbstract:
ABSTRACT: Extraintestinal pathogenic Escherichia coli (ExPEC) is a highly diverse pathotype of E. coli which colonizes the intestine, and it is considered an important etiological agent associated with bacteremia and other systemic infections, among them urinary tract infection. Retrospective studies evaluating morbidity and mortality of nondomestic felids have demonstrated that urinary tract diseases are among the main causes of death for geriatric animals. Also, mesenchymal neoplasms of the uterus are common in wild felids, and they possess variable morphologic characteristics related to invasiveness and malignancy. This report describes a case of bilateral pyelonephritis due to extraintestinal uropathogenic E. coli infection in a captive jaguar (Panthera onca). The diagnosis was confirmed through pathological, bacterial and immunohistochemical findings. According to molecular analysis, this E. coli strain was classified in the phylogroup F, possessing the following virulence-associated genes: usp, cnf-1, hlyA, papC and sfa. Additionally, this E. coli was highly resistant to β-lactams and first-generation cephalosporin. This jaguar also presented a uterine leiomyoma with distinct distribution, and severe degenerative articular disease, both of them described as frequently seen lesions in geriatric animals from the Panthera genus.
35
Mustapha, Muhammad, Yusuf Audu, Kingsley Uwakwe Ezema, Jafar Umar Abdulkadir, Jallailudeen Rabana Lawal, Arhyel Gana Balami, Lawan Adamu, and Yachilla Maryam Bukar-Kolo. "Antimicrobial Susceptibility Profiles of Escherichia Coli Isolates from Diarrheic Dogs in Maiduguri, Borno State, Nigeria." Macedonian Veterinary Review 44, no. 1 (March 1, 2021): 47–53. http://dx.doi.org/10.2478/macvetrev-2020-0035.
Full textAbstract:
Abstract Diarrhea caused by multidrug-resistant Escherichia coli (E. coli) is an important and common problem in companion animals, especially dogs. Moreover, these dogs may serve as a reservoir of pathogenic strains of E. coli that may cause enteric and extra-intestinal infections in humans and other animals. This study was conducted to investigate the antibiotic susceptibility pattern of E. coli isolates from diarrheic dogs in Maiduguri Metropolis, Borno State, Nigeria. In fecal samples of 200 dogs with diarrhea, 147 E. coli strains (73.5%) were isolated and characterized by the standard bacteriological techniques (culture, biochemical tests, and antimicrobial susceptibility testing). Out of the 147 positive isolates, 45, 50, and 52 were from Elkanemi Park, Magaram, and Sabon gari wards respectively. The isolates show 100% resistance to chloramphenicol, cefuroxime, and ceftriaxone, 96.6% to amoxicillin, and 95.9% to gentamicin, while all (100%) were susceptible to ciprofloxacin. All the isolates showed multiple antimicrobial resistance. The result of the current study showed that dogs in Maiduguri are important reservoirs of multidrug-resistant E. coli. Therefore, it is important to adopt and apply guidelines for the correct use of antimicrobials in small animal practice to reduce the emergence of multidrug resistance among E. coli in companion animals.
36
Rzewuska, Magdalena, Ilona Stefańska, Magdalena Kizerwetter-Świda, Dorota Chrobak-Chmiel, Paulina Szczygielska, Monika Leśniak, and Marian Binek. "Characterization of Extended-Spectrum-β-Lactamases Produced by Escherichia coli Strains Isolated from Dogs in Poland." Polish Journal of Microbiology 64, no. 3 (September 18, 2015): 285–88. http://dx.doi.org/10.5604/01.3001.0009.2124.
Full textAbstract:
Escherichia coli is a common cause of infections in companion animals. In recent years the increasing prevalence of resistance to β-lactams, including extended-spectrum cephalosporins, antimicrobials frequently used in small animal veterinary practice, was observed in canine isolates of E. coli. The aim of this study was to detect and to characterize extended-spectrum β-lactamases (ESBLs) produced by E. coli isolated from diseased dogs in Poland. Four isolates out of 119 studied (3.4%) were ESBL-positive. They harbored the blaSHV-12, blaCTX-M-15, and blaTEM-116 genes. This study provides the first report of the occurrence of ESBL-producing E. coli in dogs in Poland.
37
EJIDOKUN, O. O., A. WALSH, J. BARNETT, Y. HOPE, S. ELLIS, M. W. SHARP, G. A. PAIBA, M. LOGAN, G. A. WILLSHAW, and T. CHEASTY. "Human Vero cytotoxigenic Escherichia coli (VTEC) O157 infection linked to birds." Epidemiology and Infection 134, no. 2 (September 7, 2005): 421–23. http://dx.doi.org/10.1017/s0950268805004917.
Full textAbstract:
Vero cytotoxin-producing Escherichia coli O157 (VTEC O157) infections are a threat to public health. VTEC O157 has been isolated from gulls but evidence of transmission to humans from birds has not been reported. We recount an incident of VTEC O157 infection affecting two sibling children who had no direct contact with farm animals. An outbreak control team was convened to investigate the source of infection, its likely mode of transmission, and to advise on control measures. Human and veterinary samples were examined and the human isolates were found to be identical to an isolate from a sample of bird (rook) faeces. Cattle, rabbit and environmental samples were negative. This report provides evidence that birds may act as intermediaries for human infection with VTEC O157.
38
Xu, Chunming, Lingqiang Kong, Yonghong Liao, Yuan Tian, Qi Wu, Haosi Liu, and Xiumin Wang. "Mini-Review: Antibiotic-Resistant Escherichia coli from Farm Animal-Associated Sources." Antibiotics 11, no. 11 (November 2, 2022): 1535. http://dx.doi.org/10.3390/antibiotics11111535.
Full textAbstract:
Escherichia coli is one of the most frequent causes of gastro-intestinal and extra-intestinal diseases in animals and humans. Due to overuse and misuse of antibiotics, recent years have seen a rapidly increasing prevalence of antibiotic-resistant (AR) Escherichia coli globally; particularly, AR E. coli from farm animal-associated sources and its antibiotic resistance genes (ARGs) are becoming a global concern, with clinical negative effects on both human and animal health. The aim of this review was to explore the prevalence trends of AR E. coli from farm animals, waste treatment, and aquatic environments. The disinfection methods of AR E. coli and possible alternatives to antibiotics were also highlighted. The current review highlights that the prevalence of AR E. coli from food animals, products, and animal waste is increasing at an alarming rate, but is reduced at waste treatment plants. Ultraviolet (UV) treatment, surface plasma oxidation, and biochar are commonly used to effectively eliminate AR E. coli. Some probiotics, plant extracts, and antimicrobial peptides (AMPs) are arousing interest as promising alternatives to antibiotics to fight against AR E. coli. The current review suggests that AR E. coli from farm animal-associated sources is prevalent and poses a serious global threat to public health. This review provides an avenue for further research, development, and application of novel strategies to minimize antibiotic resistance in E. coli of farm animal origin.
39
PEXARA (Α. ΠΕΞΑΡΑ), A., A. S. ANGELIDIS (Α. Σ. ΑΓΓΕΛΙΔΗΣ), and A. GOVARIS (Α. ΓΚΟΒΑΡΗΣ). "Shiga toxin-producing Escherichia coli (STEC) food-borne outbreaks." Journal of the Hellenic Veterinary Medical Society 63, no. 1 (December 15, 2017): 45. http://dx.doi.org/10.12681/jhvms.15397.
Full textAbstract:
Escherichia coli (E. coli) are Gram negativo, non-sporulating bacteria, which belong to the normal intestinal flora of humans and animals. Shiga toxin-producing E. coli (STFC) arc a group of if. coli that is defined by the capacity to produce toxins called Shiga toxins (Stx). hollowing ingestion of STEC, the significant risk of two serious and potentially life-threatening complications of infection, hemorrhagic colitis and hemolytic uremic syndrome (HUS), makes STHC food poisoning a serious public health problem. Besides Stx, human pathogenic STFC harbor additional virulence factors that are important for their pathogenicity. Although human infection may also be acquired by direct transmission from person to person or by direct contact of humans with animal carriers, the majority of STFC infections are food-borne in origin.The gastrointestinal tract of healthy ruminants seems to be the foremost important reservoir for STFC and ingestion of undercooked beef one of the most likely routes of transmission to humans, Other important food sources include faecally contaminated vegetables and drinking water, The serogroup classification of STHC is based on the somatic (O) and flagellar (H) antigens, and, to date, more than 200 STFC serogroups have been identified, Human STFC infections are, however, associated with a minor subset of 0;H serotypes. Of these, the 0157:H7 or the 0157 :H- serogroups (STFC 0157) are the ones most frequently reported to be associated with food-borne outbreaks. However other non-0157 STFC serogroups such as E. coli 026, 0103, O l l i , 012I, 045 and 0145 have caused several outbreaks in recent years.Two outbreaks of gastroenteritis caused by E. coli 0157:117 were first reported in the US, following the consumption of undercooked hamburgers, in 1982. Since then several outbreaks were reported worldwide. A major E. coli 0157:117 outbreak occurred in Japan and contaminated radish sprouts was identified as the vehicle of infection. More than 6,000 school children were affected, 101 people were hospitalized with lILS and 12 deaths were recorded. The recent outbreak of STFC 0104:114 infection and HUS reported in Germany in the spring of 2011 was one of the largest outbreaks worldwide. As of 27 July, 3 126 cases of STFC infections, 773 cases of HUS including 46 deaths linked to the outbreak in Germany and occurring in the Furopean Union (FU) (including Norway), Outside the FU 8 cases of STFC and 5 cases of HUS, including 1 death have been reported in the USA, Canada and Switzerland, all with recent travel history to Germany.The present review on major STliC food-borne outbreaks recorded worldwide highlights the need for eontrol measures in order to prevent or at least minimize the occurrence of similar events in the future.
40
Bourély, Clémence, Thomas Coeffic, Jocelyne Caillon, Sonia Thibaut, Géraldine Cazeau, Eric Jouy, Nathalie Jarrige, et al. "Trends in antimicrobial resistance among Escherichia coli from defined infections in humans and animals." Journal of Antimicrobial Chemotherapy 75, no. 6 (February 12, 2020): 1525–29. http://dx.doi.org/10.1093/jac/dkaa022.
Full textAbstract:
Abstract Objectives To characterize and compare resistance trends in clinical Escherichia coli isolates from humans, food-producing animals (poultry, cattle and swine) and pets (dogs and cats). Methods Antibiogram results collected between January 2014 and December 2017 by MedQual [the French surveillance network for antimicrobial resistance (AMR) in bacteria isolated from the community] and RESAPATH (the French surveillance network for AMR in bacteria from diseased animals) were analysed, focusing on resistance to antibiotics of common interest to human and veterinary medicine. Resistance dynamics were investigated using generalized additive models. Results In total, 743 637 antibiograms from humans, 48 170 from food-producing animals and 7750 from pets were analysed. For each antibiotic investigated, the resistance proportions of isolates collected from humans were of the same order of magnitude as those from food-producing animals or pets. However, resistance trends in humans differed from those observed in pets and food-producing animals over the period studied. For example, resistance to third-generation cephalosporins and fluoroquinolones was almost always below 10% for both humans and animals. However, in contrast to the notable decreases in resistance observed in both food-producing animals and pets, resistance in humans decreased only slightly. Conclusions Despite several potential biases in the data, the resistance trends remain meaningful. The strength of the parallel is based on similar data collection in humans and animals and on a similar statistical methodology. Resistance dynamics seemed specific to each species, reflecting different antibiotic-use practices. These results advocate applying the efforts already being made to reduce antibiotic use to all sectors and all species, both in human and veterinary medicine.
41
Puvača, Nikola, and Rosa de Llanos Frutos. "Antimicrobial Resistance in Escherichia coli Strains Isolated from Humans and Pet Animals." Antibiotics 10, no. 1 (January 13, 2021): 69. http://dx.doi.org/10.3390/antibiotics10010069.
Full textAbstract:
Throughout scientific literature, we can find evidence that antimicrobial resistance has become a big problem in the recent years on a global scale. Public healthcare systems all over the world are faced with a great challenge in this respect. Obviously, there are many bacteria that can cause infections in humans and animals alike, but somehow it seems that the greatest threat nowadays comes from the Enterobacteriaceae members, especially Escherichia coli. Namely, we are witnesses to the fact that the systems that these bacteria developed to fight off antibiotics are the strongest and most diverse in Enterobacteriaceae. Our great advantage is in understanding the systems that bacteria developed to fight off antibiotics, so these can help us understand the connection between these microorganisms and the occurrence of antibiotic-resistance both in humans and their pets. Furthermore, unfavorable conditions related to the ease of E. coli transmission via the fecal–oral route among humans, environmental sources, and animals only add to the problem. For all the above stated reasons, it is evident that the epidemiology of E. coli strains and resistance mechanisms they have developed over time are extremely significant topics and all scientific findings in this area will be of vital importance in the fight against infections caused by these bacteria.
42
Cheasty, T. "Escherichia coli in domestic animals and humans." Transactions of the Royal Society of Tropical Medicine and Hygiene 89, no. 5 (September 1995): 580–81. http://dx.doi.org/10.1016/0035-9203(95)90125-6.
Full text
43
Bertelloni, Fabrizio, Giulia Cagnoli, Fabrizio Biagini, Alessandro Poli, Carlo Bibbiani, and Valentina Virginia Ebani. "Virulence Genes of Pathogenic Escherichia coli in Wild Red Foxes (Vulpes vulpes)." Animals 12, no. 15 (August 2, 2022): 1959. http://dx.doi.org/10.3390/ani12151959.
Full textAbstract:
Different pathotypes of Escherichia coli can cause severe diseases in animals and humans. Wildlife may contribute to the circulation of pathogenic pathotypes, including enteropathogenic E. coli (EPEC), Shiga toxin-producing E. coli (STEC), and enterohemorrhagic E. coli (EHEC). This study analyzed 109 DNA samples previously extracted from fecal specimens collected from red foxes (Vulpes vulpes) to detect E. coli virulence genes eaeA, hlyA, stx1, and stx2, that characterize the EPEC, STEC, and EHEC strains. Thirty-one (28.4%) samples were positive for at least one investigated virulence gene: eaeA gene was detected in 21 (19.2%) samples, hlyA in 10 (9.1%), stx1 in 6 (5.5%), and stx2 in 4 (3.6%). Nine DNA samples resulted positive for two or three virulence genes: five (4.6%) samples were positive for eaeA and hlyA genes, two (1.8%) for eaeA and stx1, one (0.9%) for hlyA and stx1, one (0.9%) for eaeA, hlyA and stx2. Red foxes seem to be involved in the epidemiology of these infections and their role could be relevant because they may be source of pathogenic E. coli for other wild animals, as well as domestic animals and humans.
44
Ewaschuk, Julia B., Gordon K. Murdoch, Ian R. Johnson, Karen L. Madsen, and Catherine J. Field. "Glutamine supplementation improves intestinal barrier function in a weaned piglet model of Escherichia coli infection." British Journal of Nutrition 106, no. 6 (May 18, 2011): 870–77. http://dx.doi.org/10.1017/s0007114511001152.
Full textAbstract:
The weaning period is associated with an increased prevalence of gastrointestinal infection in many species. Glutamine (Gln) has been shown to improve intestinal barrier function and immune function in both in vivo and in vitro models. The objective of the present study was to determine the effect of dietary Gln supplementation on intestinal barrier function and intestinal cytokines in a model of Escherichia coli infection. We randomised 21-d-old piglets (n 20) to nutritionally complete isonitrogenous diets with or without Gln (4·4 %, w/w) for 2 weeks. Intestinal loops were isolated from anaesthetised pigs and inoculated with either saline or one of the two E. coli (K88AC or K88 wild-type)-containing solutions. Intestinal tissue was studied for permeability, cytokine expression, fluid secretion and tight-junction protein expression. Animals receiving Gln supplementation had decreased potential difference (PD) and short-circuit current (Isc) in E. coli-inoculated intestinal loops (PD 0·628 (sem 0·151) mV; Isc 13·0 (sem 3·07) μA/cm2) compared with control-fed animals (PD 1·36 (sem 0·227) mV; Isc 22·4 (sem 2·24) μA/cm2). Intestinal tissue from control, but not from Gln-supplemented, animals responded to E. coli with a significant increase in mucosal cytokine mRNA (IL-1β, IL-6, transforming growth factor-β and IL-10). Tight-junction protein expression (claudin-1 and occludin) was reduced with exposure to E. coli in control-fed animals and was not influenced in Gln-supplemented piglets. Gln supplementation may be useful in reducing the severity of weaning-related gastrointestinal infections, by reducing the mucosal cytokine response and altering intestinal barrier function.
45
Kilani, Hajer, Mohamed Salah Abbassi, Sana Ferjani, Rakia Ben Salem, Riadh Mansouri, Noureddine Ben Chehida, and Ilhem Boutiba-Ben Boubaker. "Diverse Escherichia coli pathovars of phylogroups B2 and D isolated from animals in Tunisia." Journal of Infection in Developing Countries 11, no. 07 (July 31, 2017): 549–56. http://dx.doi.org/10.3855/jidc.8579.
Full textAbstract:
Introduction: The virulent Escherichia coli strains responsible for extraintestinal infections were mainly belonged to B2 and D phylogroups. However, no past studies have determinate via the presence of virulence genes the frequency of E. coli pathovars recovered from animals housed in farms in Tunisia. The aims of this study were to investigate 26 E. coli isolated from healthy and diarrheic animals and to determinate via the presence of virulence genes the frequency of pathovars.
Methodology: Twenty-six E. coli isolates of phylogroups B2 (n = 14), B22 (n = 9), B23 (n = 5), and D2 (n = 12) were characterized. Genes encoding virulence factors (fimH,eaeA,aggC,papC, papG allele III, hlyA, east1, cnf1, exhA,stx1, stx2, iutA, fyuA, ibeA,and ipaH), and antibiotic resistance as well as class 1 and 2 integrons were searched by polymerase chain reaction (PCR). The genetic relationship of isolates was done by PFGE.
Results: According to the occurrence of specific genes the 26 isolates were classified as:9 EAEC, 2 EHEC, 4 UPEC, 3 EPEC/EHEC and 1 NTEC. Therefore, 2 Ex-PEC and 5 APEC were presented amongst our strains. Some isolates (12) were clonal and the remaining was unrelated.
Conclusions: Higher diversity of pathovars which carried diverse combinations of virulence genes in healthy isolates. In addition, it seems that the infections were caused by different mechanisms.
46
Calderon Toledo, Carla, Ida Arvidsson, and Diana Karpman. "Cross-Reactive Protection against Enterohemorrhagic Escherichia coli Infection by Enteropathogenic E. coli in a Mouse Model." Infection and Immunity 79, no. 6 (March 14, 2011): 2224–33. http://dx.doi.org/10.1128/iai.01024-10.
Full textAbstract:
ABSTRACTEnteropathogenicEscherichia coli(EPEC) and enterohemorrhagicE. coli(EHEC) are related attaching and effacing (A/E) pathogens. The genes responsible for the A/E pathology are carried on a chromosomal pathogenicity island termed the locus of enterocyte effacement (LEE). Both pathogens share a high degree of homology in the LEE and additional O islands. EHEC prevalence is much lower in areas where EPEC is endemic. This may be due to the development of antibodies against common EPEC and EHEC antigens. This study investigated the hypothesis that EPEC infections may protect against EHEC infections. We used a mouse model to inoculate BALB/c mice intragastrically, first with EPEC and then with EHEC (E. coliO157:H7). Four control groups received either a nonpathogenicE. coli(NPEC) strain followed by EHEC (NPEC/EHEC), phosphate-buffered saline (PBS) followed by EHEC (PBS/EHEC), EPEC/PBS, or PBS/PBS. Mice were monitored for weight loss and symptoms. EPEC colonized the intestine after challenge, and mice developed serum antibodies to intimin andE. colisecreted protein B (encoded in the LEE). Prechallenge with an EPEC strain had a protective effect after EHEC infection, as only a few mice developed mild symptoms, from which they recovered. These mice had an increase in body weight similar to that in control animals, and tissue morphology exhibited mild intestinal changes and normal renal histology. All mice that were not prechallenged with the EPEC strain developed mild to severe symptoms after EHEC infection, with weight loss as well as intestinal and renal histopathological changes. These data suggest that EPEC may protect against EHEC infection in this mouse model.
47
Mohamed, S. A., and C. Mathew. "Antimicrobial Activity of Bidens pilosa Leaves Extracts Against Staphylococcus aureus and Escherichia coli." Tanzania Veterinary Journal 38 (August 30, 2021): 20–24. http://dx.doi.org/10.4314/tvj.v38i1.4s.
Full textAbstract:
Resistance against synthetic antimicrobial agents is one of the major global public health challenges that compel scientists to search for alternatives including those of plants origin. Staphylococcus aureus and Escherichia coli are bacteria responsible for a variety of infections and diseases that causes significant morbidity and mortality in humans and animals. E. coli is widely distributed in nature and commonly found in lower gastro intestinal tracts of most warm-blooded animals associated with urinary tract infections and enterocolitis in humans and colibacillosis in poultry. This study was carried out to investigate antimicrobial activity of methanolic leaf extracts of Bidens pilosa against S. aureus and E. coli. Agar well diffusion method was used to assess antimicrobial activity of the leaf extracts at 20%, 50% and 70% concentrations respectively based on measured zone of inhibition. The leaf extracts of Bidens pilosa produced significant zone of inhibition indicating its antimicrobial activity against E. coli and S. aureus. The antimicrobial activity was demonstrated in all concentrations however, the highest zone of inhibition (18.5mm and 32mm) for E. coli and S. aureus respectively was at 70% concentration. The results shows that Bidens pilosa leaf extracts have antimicrobial activity against the tested bacteria and have the potential for further development including identification of active components that can be tested for treatment of E. coli and S. aureus associated conditions.
48
Caruso, Giorgia. "Antibiotic Resistance in Escherichia coli from Farm Livestock and Related Analytical Methods: A Review." Journal of AOAC INTERNATIONAL 101, no. 4 (July 1, 2018): 916–22. http://dx.doi.org/10.5740/jaoacint.17-0445.
Full textAbstract:
Abstract The indiscriminate use of antibiotics for the treatment of human and animal infections has led to the rise of resistance in pathogens and in commensal bacteria. In particular, farm animals may act as vectors for the dissemination of drug-resistant genes because of the intensive use of antibiotics in animal production, enabling resistance to a wide range of antimicrobial agents, including those normally used in human medicine. Escherichia coli, being a widespread commensal, is considered a good indicator of antibiotic use. Ultimately, it is emerging as a global threat, developing dramatically high levels of antibiotic resistance to multiple classes of drugs. Its prevalence in food animals is hence alarming, and more studies are needed in order to ascertain the spread dynamics between the food chain and humans. In this context, great attention should be paid to the accurate detection of resistance by conventional and molecular methods. In this review, a comprehensive list of the most widely used testing methods is also addressed.
49
Stetsko, T. I., Ya M. Liubenko, V. N. Padovskyi, L. L. Ostrovska, O. Yo Kalinina, and O. Z. Balyan. "Investigation of the antimicrobial activity of danofoloxacin against bacteria pathogens in goats." Scientific Messenger of LNU of Veterinary Medicine and Biotechnologies 22, no. 97 (May 7, 2020): 74–78. http://dx.doi.org/10.32718/nvlvet9713.
Full textAbstract:
Fluoroquinolones are critical antimicrobials for both human and veterinary medicine. Due to their unique mechanism of antimicrobial action and good pharmacokinetic properties, they are often the first choice drugs in the treatment of bacterial infections in animals. The purpose of the investigation was to study the antimicrobial activity of a third-generation fluoroquinolone antibiotic of danofloxacin against bacteria, pathogens of respiratory and intestinal infection in goats. The samples of the nasal outflows (respiratory infection) and fecal masses (intestinal infection) were collected from clinically ill goats for microbiological studies. The sensitivity test of the microflora of the biomaterial, carried out by the disco-diffusion method, showed that the microorganisms of all the samples were sensitive to danofloxacin. Bacteria Streptococcus pneumonia (n = 10), Staphylococcus aureus (n = 4) and Escherichia coli (n = 2) were isolated and identified from nasal exudate samples (n = 10). Pathogenic strains of Escherichia coli were isolated from all faecal samples (n = 12). The degree of bacteriostatic activity of danofloxacin was determined by establishing its minimum inhibitory concentration (MIC) for bacterial isolates by sequential dilutions in a liquid nutrient medium. The average MIC of danofloxacin for Streptococcus pneumoniae isolates was 0.26 ± 0.13 μg/ml and for Staphylococcus aureus isolates – 0.25 ± 0.075 μg/ml. For Escherichia coli strains isolated from faeces of goats suffering from coli infection, the average MIC of danofloxacin was 0.38 ± 0.12 μg/ml (range 0.2 to 0.8 μg/ml). Antimicrobial sensitivity testing have shown a high level of bacteriostatic activity of danofloxacin against bacteria, pathogens of respiratory and intestinal infections in goats. This may be the argument for the use of danofloxacin-based chemotherapeutic agents in the treatment of bacterial infections in goats, especially for the empirical approach to therapy.
50
Lisboa, Szelewicki, Lin, Latonas, Li, Zhi, Parsons, Berenger, Fathima, and Chui. "Epidemiology of Shiga Toxin-Producing Escherichia coli O157 in the Province of Alberta, Canada, 2009–2016." Toxins 11, no. 10 (October 22, 2019): 613. http://dx.doi.org/10.3390/toxins11100613.
Full textAbstract:
Shiga toxin-producing Escherichia coli (STEC) infections are the product of the interaction between bacteria, phages, animals, humans, and the environment. In the late 1980s, Alberta had one of the highest incidences of STEC infections in North America. Herein, we revisit and contextualize the epidemiology of STEC O157 human infections in Alberta for the period 2009–2016. STEC O157 infections were concentrated in large urban centers, but also in rural areas with high cattle density. Hospitalization was often required when the Shiga toxin genotype stx2a stx2c was involved, however, only those aged 60 years or older and infection during spring months (April to June) independently predicted that need. Since the late 1980s, the rate of STEC O157-associated hemolytic uremic syndrome (HUS) in Alberta has remained unchanged at 5.1%, despite a marked drop in the overall incidence of the infection. While Shiga toxin genotypes stx1a stx2c and stx2a stx2c seemed associated with HUS, only those aged under 10 years and infection during spring months were independently predictive of that complication. The complexity of the current epidemiology of STEC O157 in Alberta highlights the need for a One Health approach for further progress to be made in mitigating STEC morbidity.